{"id":"W2587369397","doi":"10.1186/s12883-017-0799-0","title":"Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial","year":2017,"lang":"en","type":"article","venue":"BMC Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Medicine; Multiple sclerosis; Neurology; Placebo; Magnetic resonance imaging; Randomized controlled trial; Neurochemistry; Internal medicine; Clinical trial; Neurosurgery; Nuclear medicine; Gastroenterology; Surgery; Radiology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003152693,0.001358653,0.003691981,0.0004737353,0.0002586983,0.0008718939,0.000737534,0.00148506,0.004253728],"category_scores_gemma":[0.002805008,0.0005044398,0.002683241,0.0004020086,0.0005849626,0.001033408,0.0005382582,0.001735739,0.0003839698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000378108,"about_ca_system_score_gemma":0.0005334101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003940854,"about_ca_topic_score_gemma":0.000684502,"domain_scores_codex":[0.9988907,0.0005921174,0.0001041127,0.0001913404,0.0001288756,0.00009298668],"domain_scores_gemma":[0.9978418,0.000672641,0.0008077736,0.0002028748,0.000140546,0.0003341906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9849976,0.001828086,0.001312805,0.0004849597,0.001711866,0.00002782264,0.00001960194,0.0002831748,0.001009427,0.00005320696,0.0004201031,0.007851257],"study_design_scores_gemma":[0.9454652,0.04071581,0.009938403,0.00007306517,0.002000083,0.00007152811,0.00001452619,0.0005236549,0.0003558592,0.0001111031,0.000712414,0.00001828708],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847499,0.00989693,0.0004507496,0.0005110958,0.0002716236,0.001135414,0.001214837,0.00008048162,0.001688902],"genre_scores_gemma":[0.9873536,0.004474549,0.001574856,0.0007774213,0.0006640372,0.001693579,0.001584145,0.00001861239,0.001859192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004253728,"threshold_uncertainty_score":0.01667327,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05709993393135038,"score_gpt":0.2994747352437943,"score_spread":0.2423748013124439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}